Risk factors for nephropathy in individuals with new-onset type 2 diabetes undergoing treatment for hypertension: A retrospective analysis using the Diagnosis Procedure Combination database

BACKGROUNDDiabetic nephropathy is a common complication of diabetes. We investigated the risk factors for diabetic nephropathy in individuals newly diagnosed with type 2 diabetes.METHODSData from the Japanese Diagnosis Procedure Combination in-patient database (April 2008 to December 2018) were anal...

Full description

Saved in:
Bibliographic Details
Published inAnnals of Clinical Epidemiology Vol. 7; no. 3; pp. 71 - 79
Main Authors Ishigaki Suzuki, Tomoko, Saito Oba, Mari, Uemura, Kohei
Format Journal Article
LanguageEnglish
Published Japan Society for Clinical Epidemiology 01.07.2025
一般社団法人 日本臨床疫学会
Subjects
Online AccessGet full text
ISSN2434-4338
2434-4338
DOI10.37737/ace.25009

Cover

Abstract BACKGROUNDDiabetic nephropathy is a common complication of diabetes. We investigated the risk factors for diabetic nephropathy in individuals newly diagnosed with type 2 diabetes.METHODSData from the Japanese Diagnosis Procedure Combination in-patient database (April 2008 to December 2018) were analyzed. The endpoint was subsequent diabetic nephropathy diagnosis or as the time when estimated glomerular filtration rate become <60 ml/min/1.73 m2. Candidate risk factors included age, Hemoglobin A1c, log-transformed triglyceride, total cholesterol, and high-density lipoprotein cholesterol levels, body mass index, and estimated glomerular filtration rate. Eligible individuals with type 2 diabetes without complications who had pre- and post-diagnosis Hemoglobin A1c and serum creatinine measurements, and a history of hypertension or cardiovascular disease pre-diagnosis. Those with pre-existing kidney diseases, nephropathy onset pre-diagnosis, estimated glomerular filtration rate <60 ml/min/1.73 m2 on or before diabetes diagnosis, or age <20 years at diabetes diagnosis were excluded. A multivariate Cox proportional hazards model (p = 0.2 backward selection) was employed.RESULTSOf 2,664 eligible individuals (1,775 men, 889 women), 325 men and 175 women developed diabetic nephropathy during follow-up. Cumulative incidence within 5 years was 29.0% in men and 32.5% in women. Age and estimated glomerular filtration rate in both sexes, and total cholesterol in men were significant.CONCLUSIONSAge, estimated glomerular filtration rate, and lipid pose potential risks for diabetic nephropathy onset within 5 years of diabetes diagnosis in individuals with hypertension. Collectively, our findings highlight the importance of early monitoring and intervention in this high-risk.
AbstractList Diabetic nephropathy is a common complication of diabetes. We investigated the risk factors for diabetic nephropathy in individuals newly diagnosed with type 2 diabetes.BACKGROUNDDiabetic nephropathy is a common complication of diabetes. We investigated the risk factors for diabetic nephropathy in individuals newly diagnosed with type 2 diabetes.Data from the Japanese Diagnosis Procedure Combination in-patient database (April 2008 to December 2018) were analyzed. The endpoint was subsequent diabetic nephropathy diagnosis or as the time when estimated glomerular filtration rate become <60 ml/min/1.73 m2. Candidate risk factors included age, Hemoglobin A1c, log-transformed triglyceride, total cholesterol, and high-density lipoprotein cholesterol levels, body mass index, and estimated glomerular filtration rate. Eligible individuals with type 2 diabetes without complications who had pre- and post-diagnosis Hemoglobin A1c and serum creatinine measurements, and a history of hypertension or cardiovascular disease pre-diagnosis. Those with pre-existing kidney diseases, nephropathy onset pre-diagnosis, estimated glomerular filtration rate <60 ml/min/1.73 m2 on or before diabetes diagnosis, or age <20 years at diabetes diagnosis were excluded. A multivariate Cox proportional hazards model (p = 0.2 backward selection) was employed.METHODSData from the Japanese Diagnosis Procedure Combination in-patient database (April 2008 to December 2018) were analyzed. The endpoint was subsequent diabetic nephropathy diagnosis or as the time when estimated glomerular filtration rate become <60 ml/min/1.73 m2. Candidate risk factors included age, Hemoglobin A1c, log-transformed triglyceride, total cholesterol, and high-density lipoprotein cholesterol levels, body mass index, and estimated glomerular filtration rate. Eligible individuals with type 2 diabetes without complications who had pre- and post-diagnosis Hemoglobin A1c and serum creatinine measurements, and a history of hypertension or cardiovascular disease pre-diagnosis. Those with pre-existing kidney diseases, nephropathy onset pre-diagnosis, estimated glomerular filtration rate <60 ml/min/1.73 m2 on or before diabetes diagnosis, or age <20 years at diabetes diagnosis were excluded. A multivariate Cox proportional hazards model (p = 0.2 backward selection) was employed.Of 2,664 eligible individuals (1,775 men, 889 women), 325 men and 175 women developed diabetic nephropathy during follow-up. Cumulative incidence within 5 years was 29.0% in men and 32.5% in women. Age and estimated glomerular filtration rate in both sexes, and total cholesterol in men were significant.RESULTSOf 2,664 eligible individuals (1,775 men, 889 women), 325 men and 175 women developed diabetic nephropathy during follow-up. Cumulative incidence within 5 years was 29.0% in men and 32.5% in women. Age and estimated glomerular filtration rate in both sexes, and total cholesterol in men were significant.Age, estimated glomerular filtration rate, and lipid pose potential risks for diabetic nephropathy onset within 5 years of diabetes diagnosis in individuals with hypertension. Collectively, our findings highlight the importance of early monitoring and intervention in this high-risk.CONCLUSIONSAge, estimated glomerular filtration rate, and lipid pose potential risks for diabetic nephropathy onset within 5 years of diabetes diagnosis in individuals with hypertension. Collectively, our findings highlight the importance of early monitoring and intervention in this high-risk.
INTRODUCTION: Diabetic nephropathy is a common complication of diabetes. We investigated the risk factors for diabetic nephropathy in individuals newly diagnosed with type 2 diabetes.METHODS: Data from the Japanese Diagnosis Procedure Combination in-patient database (April 2008 to December 2018) were analyzed. The endpoint was subsequent diabetic nephropathy diagnosis or as the time when estimated glomerular filtration rate become < 60 ml/min/1.73 m2. Candidate risk factors included age; Hemoglobin A1c, log-transformed triglyceride, total cholesterol, and high-density lipoprotein cholesterol levels; body mass index; and estimated glomerular filtration rate. Eligible individuals with type 2 diabetes without complications who had pre- and post-diagnosis Hemoglobin A1c and serum creatinine measurements, and a history of hypertension or cardiovascular disease pre-diagnosis. Those with pre-existing kidney diseases, nephropathy onset pre-diagnosis, estimated glomerular filtration rate < 60 ml/min/1.73 m2 on or before diabetes diagnosis, or age < 20 years at diabetes diagnosis were excluded. A multivariate Cox proportional hazards model (p = 0.2 backward selection) was employed.RESULTS: Of 2,664 eligible individuals (1,775 men, 889 women), 325 men and 175 women developed diabetic nephropathy during follow-up. Cumulative incidence within 5 years was 29.0% in men and 32.5% in women. Age and estimated glomerular filtration rate in both sexes, and total cholesterol in men were significant.CONCLUSION: Age, estimated glomerular filtration rate, and lipid pose potential risks for diabetic nephropathy onset within 5 years of diabetes diagnosis in individuals with hypertension. Collectively, our findings highlight the importance of early monitoring and intervention in this high-risk.
BACKGROUNDDiabetic nephropathy is a common complication of diabetes. We investigated the risk factors for diabetic nephropathy in individuals newly diagnosed with type 2 diabetes.METHODSData from the Japanese Diagnosis Procedure Combination in-patient database (April 2008 to December 2018) were analyzed. The endpoint was subsequent diabetic nephropathy diagnosis or as the time when estimated glomerular filtration rate become <60 ml/min/1.73 m2. Candidate risk factors included age, Hemoglobin A1c, log-transformed triglyceride, total cholesterol, and high-density lipoprotein cholesterol levels, body mass index, and estimated glomerular filtration rate. Eligible individuals with type 2 diabetes without complications who had pre- and post-diagnosis Hemoglobin A1c and serum creatinine measurements, and a history of hypertension or cardiovascular disease pre-diagnosis. Those with pre-existing kidney diseases, nephropathy onset pre-diagnosis, estimated glomerular filtration rate <60 ml/min/1.73 m2 on or before diabetes diagnosis, or age <20 years at diabetes diagnosis were excluded. A multivariate Cox proportional hazards model (p = 0.2 backward selection) was employed.RESULTSOf 2,664 eligible individuals (1,775 men, 889 women), 325 men and 175 women developed diabetic nephropathy during follow-up. Cumulative incidence within 5 years was 29.0% in men and 32.5% in women. Age and estimated glomerular filtration rate in both sexes, and total cholesterol in men were significant.CONCLUSIONSAge, estimated glomerular filtration rate, and lipid pose potential risks for diabetic nephropathy onset within 5 years of diabetes diagnosis in individuals with hypertension. Collectively, our findings highlight the importance of early monitoring and intervention in this high-risk.
Diabetic nephropathy is a common complication of diabetes. We investigated the risk factors for diabetic nephropathy in individuals newly diagnosed with type 2 diabetes. Data from the Japanese Diagnosis Procedure Combination in-patient database (April 2008 to December 2018) were analyzed. The endpoint was subsequent diabetic nephropathy diagnosis or as the time when estimated glomerular filtration rate become <60 ml/min/1.73 m . Candidate risk factors included age, Hemoglobin A1c, log-transformed triglyceride, total cholesterol, and high-density lipoprotein cholesterol levels, body mass index, and estimated glomerular filtration rate. Eligible individuals with type 2 diabetes without complications who had pre- and post-diagnosis Hemoglobin A1c and serum creatinine measurements, and a history of hypertension or cardiovascular disease pre-diagnosis. Those with pre-existing kidney diseases, nephropathy onset pre-diagnosis, estimated glomerular filtration rate <60 ml/min/1.73 m on or before diabetes diagnosis, or age <20 years at diabetes diagnosis were excluded. A multivariate Cox proportional hazards model (p = 0.2 backward selection) was employed. Of 2,664 eligible individuals (1,775 men, 889 women), 325 men and 175 women developed diabetic nephropathy during follow-up. Cumulative incidence within 5 years was 29.0% in men and 32.5% in women. Age and estimated glomerular filtration rate in both sexes, and total cholesterol in men were significant. Age, estimated glomerular filtration rate, and lipid pose potential risks for diabetic nephropathy onset within 5 years of diabetes diagnosis in individuals with hypertension. Collectively, our findings highlight the importance of early monitoring and intervention in this high-risk.
ArticleNumber 25009
Author Tomoko Ishigaki Suzuki
Kohei Uemura
Mari Saito Oba
Author_xml – sequence: 1
  givenname: Tomoko
  surname: Ishigaki Suzuki
  fullname: Ishigaki Suzuki, Tomoko
– sequence: 2
  givenname: Mari
  surname: Saito Oba
  fullname: Saito Oba, Mari
– sequence: 3
  givenname: Kohei
  surname: Uemura
  fullname: Uemura, Kohei
BackLink https://cir.nii.ac.jp/crid/1390866117160927104$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/40697797$$D View this record in MEDLINE/PubMed
BookMark eNp9Uttu1DAQjVARLaUvfADyAw8ItMWXbJwgIVQtV6kSCMGzNXEmG5esHWxnV_tx_BtOtizlBck3zZw5MzrHD7MT6yxm2WNGL4WUQr4EjZd8SWl1LzvjucgXuRDlyZ33aXYRwg2llEvJaLV8kJ3mtKikrORZ9uurCT9ICzo6H0jrPLE4dN4NELs9MTatxmxNM0IfyM7ELuV3C2cDRhL3AxJOGgM1RgxktA36tTN2TaJHiBu0cabsEtBHtME4-4pcEY_RuzCgjmaLBCz0-2BSfZhLOyRvDaytm2JfvNPYjB7Jym1qYyEmDtJAhBoCPsrut2kwvLi9z7Pv7999W31cXH_-8Gl1db3QQvBq0S5B82VZ6zJvc1FrUVdFytQ8TyowwSdlGtmysgYtkVWa1a3WXMsiL3hRLcV59uLAO9oB9jvoezV4swG_V4yq2QeVfFCzDwn95oAexnqDjU4yePhb4cCofzPWdGrttopxLquc5onh2S2Ddz9HDFFtTNDY92DRjUEJLnhelkXBEvTJ3WbHLn8sToDnB4BOmgeP7f9Hf3oAW2OUNtPJREWnTkyyglY8faFpvtcH2E2IsMYjI_hodI8zoVQi7Zn2GNcdeIVW_AYSDt3q
Cites_doi 10.1093/aje/kwv214
10.2337/db05-1620
10.1007/s00125-019-4939-5
10.1097/MD.0000000000003013
10.1016/j.je.2016.09.009
10.1097/01.ede.0000135174.63482.43
10.21037/apm-21-2673
10.1007/s13340-021-00497-3
10.1093/aje/kwv225
10.1136/jech-2023-221759
10.1093/aje/kwv215
10.1136/bmjdrc-2019-000902
10.4009/jsdt.55.665
10.1053/j.ajkd.2008.12.034
10.1136/bmjdrc-2016-000291
10.1038/sj.ki.5002017
10.1046/j.1523-1755.2000.00166.x
10.2337/diacare.26.3.638
10.1093/aje/kwv219
10.2337/dc24-S011
10.1007/s00125-012-2796-6
ContentType Journal Article
Copyright 2025 Society for Clinical Epidemiology
2025 Society for Clinical Epidemiology.
2025 Society for Clinical Epidemiology 2025 Society for Clinical Epidemiology
Copyright_xml – notice: 2025 Society for Clinical Epidemiology
– notice: 2025 Society for Clinical Epidemiology.
– notice: 2025 Society for Clinical Epidemiology 2025 Society for Clinical Epidemiology
DBID RYH
AAYXX
CITATION
NPM
7X8
5PM
ADTOC
UNPAY
DOI 10.37737/ace.25009
DatabaseName CiNii Complete
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate RISKS OF DIABETIC NEPHROPATHY UNDER HYPERTENSION
EISSN 2434-4338
EndPage 79
ExternalDocumentID 10.37737/ace.25009
PMC12279404
40697797
10_37737_ace_25009
article_ace_7_3_7_25009_article_char_en
Genre Journal Article
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
GROUPED_DOAJ
JSF
JSH
M~E
OK1
PGMZT
RJT
RPM
RZJ
RYH
AAYXX
CITATION
NPM
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c3329-f5ac258bc84f43bc3b96c33b249771320277d7f18bac7e19c1bfcc2c764626953
IEDL.DBID UNPAY
ISSN 2434-4338
IngestDate Sun Oct 26 02:45:41 EDT 2025
Thu Aug 21 18:25:25 EDT 2025
Thu Jul 24 01:46:54 EDT 2025
Sat Jul 26 01:47:28 EDT 2025
Wed Oct 01 05:53:06 EDT 2025
Thu Jun 26 21:13:29 EDT 2025
Wed Sep 03 06:30:47 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords hypertension treatment
Onset of diabetic nephropathy
new type 2 diabetes
risk factor
Language English
License https://creativecommons.org/licenses/by-nc-nd/4.0
2025 Society for Clinical Epidemiology.
This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
cc-by-nc-nd
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3329-f5ac258bc84f43bc3b96c33b249771320277d7f18bac7e19c1bfcc2c764626953
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=https://doi.org/10.37737/ace.25009
PMID 40697797
PQID 3232488661
PQPubID 23479
PageCount 9
ParticipantIDs unpaywall_primary_10_37737_ace_25009
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12279404
proquest_miscellaneous_3232488661
pubmed_primary_40697797
crossref_primary_10_37737_ace_25009
nii_cinii_1390866117160927104
jstage_primary_article_ace_7_3_7_25009_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-Jul-01
PublicationDateYYYYMMDD 2025-07-01
PublicationDate_xml – month: 07
  year: 2025
  text: 2025-Jul-01
  day: 01
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Annals of Clinical Epidemiology
PublicationTitleAlternate Ann Clin Epidemiol
PublicationTitle_FL Annals of Clinical Epidemiology
Ann Clin Epidemiol
ACE
PublicationYear 2025
Publisher Society for Clinical Epidemiology
一般社団法人 日本臨床疫学会
Publisher_xml – name: Society for Clinical Epidemiology
– name: 一般社団法人 日本臨床疫学会
References 1. Ministry of Health,. Labour and Welfare. The National Health and Nutrition Survey in Japan, 2019 (in Japanese). Available at https://www.mhlw.go.jp/content/10900000/000687163.pdf pp.20 Last accessed March 13, 2024
18. American Diabetes Association. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes - 2024. Diabetes Care. 2024;47:S219–S230.
5. Retnakaran R, Cull CA, Thorne KI, et al. Risk factors for renal dysfunction in type 2 diabetes: UK Prospective Diabetes Study 74. Diabetes. 2006;55:1832–1839.
6. Katakura M, Yamauchi K, Naka M, et al. Prospective analysis of mortality and risk factors in elderly diabetic subjects: Nagano Study. Diabetic Care. 2003;26:638–644.
19. Tsai WC, Wu HY, Peng YS, et al. Risk factors for development and progression of chronic kidney disease: A systematic review and exploratory meta-analysis. Medicine. 2016;95:e3013.
13. Brookhart MA. Counterpoint: The treatment decision design. Am J Epidemiol. 2015;182:840–845.
26. Huebschmann AG, Huxley RR, Kohrt WM, et al. Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia. 2019;62:1761–1772.
3. Yokoyama H, Okudaira M, Otani T, et al. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Kidney Int. 2000;58:302–311.
14. Vandenbroucke J, Pearce N. Response to point-counterpoint: Vandenbroucke and Pearce respond to “Incident and Prevalent Exposures and Causal Inference”. Am J Epidemiol. 2015;182;846–847.
22. Yamana H, Moriwaki M, Horiguchi H, et al. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27:476–482.
8. Makino H. Diabetic nephropathy development and progression mechanism and treatment. pp. 6, 1999, Shindan to Chiryo Sha. (in Japanese).
23. Tanaka H, Tomio J, Sugiyama T, et al. Process quality of diabetes care under favorable access to healthcare: a 2-year longitudinal study using claims data in Japan. BMJ Open Diabetes Res Care. 2016;4:e000291.
9. Szkio M, Nieto FJ. Epidemiology: beyond the basics. 4th ed. pp. 157, 2019, Jones & Bartlett Learning, Burlington, Massachusetts.
20. Yamagata K, Ishida K, Sairenchi T, et al. Risk factors for chronic kidney disease in a community-based population: A 10-year follow-up study. Int Soc Nep. 2007;71:159–166.
2. Hanafusa N, Abe M, Joki N, et al. 2021 Annual Dialysis Data Report, JSDT Renal Data Registry. J Jpn Soc Dial Ther. 2022;55:665–723 (in Japanese).
12. Hernán MA. Counterpoint: Epidemiology to guide decision-making: Moving away from practice-free research. Am J Epidemiol. 2015;182:834–839.
21. Lv J, Ren C, Hu Q. Effect of statins on the treatment of early diabetic nephropathy: A systematic review and meta-analysis of nine randomized controlled trials. Ann Palliat Med. 2021;10:11548–11557.
17. KDIGO 2022 Clinical Practice Guideline for Diabetes management in Chronic Kidney Disease. Available at https://pubmed.ncbi.nlm.nih.gov/36272764/ pp. 59 Last accessed October 27, 2024.
24. Mitri J, Sugiyama T, Tanaka H, et al. Understanding the quality of diabetes care in Japan: a systematic review of the literature. Diabetology Int. 2022;13:41–48.
7. Sone H, Saitou Y, Yoshimura Y, et al. Diabetes mellitus and complications recent trends in the Japanese population. Jpn J Internal Medicine. 2004;93:131–138 (in Japanese).
10. Hernán MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15:615–625.
25. He F, Xia X, Wu XF, et al. Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis. Diabetetologia. 2013;56:457–466.
11. Vandenbroucke J, Pearce N. Point: Incident exposures, prevalent exposures, and causal inference: Does limiting studies to persons who are followed from first exposure onward damage epidemiology? Am J Epidemiol. 2015;182:826–833.
4. The Japanese Diabetes Society. Guidelines for Diabetes Treatment. 2019. pp. 145–151, 2020, Nankou-dou, Tokyo, Japan (in Japanese).
27. Gibson AA, Cox E, Schneuer F, et al. Sex differences in risk of incident microvascular and macrovascular complications: a population-based data-linkage study among 25713 people with diabetes. J Epidemiol Community Health. 2024;10;78:479–486.
15. Yoshida Y, Kashiwabara K, Hirakawa Y, et al. Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan. BMJ Open Diabetes Res Care. 2020;8:e000902.
16. Matsuno S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–992.
22
23
24
25
26
27
10
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – reference: 6. Katakura M, Yamauchi K, Naka M, et al. Prospective analysis of mortality and risk factors in elderly diabetic subjects: Nagano Study. Diabetic Care. 2003;26:638–644.
– reference: 16. Matsuno S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–992.
– reference: 19. Tsai WC, Wu HY, Peng YS, et al. Risk factors for development and progression of chronic kidney disease: A systematic review and exploratory meta-analysis. Medicine. 2016;95:e3013.
– reference: 4. The Japanese Diabetes Society. Guidelines for Diabetes Treatment. 2019. pp. 145–151, 2020, Nankou-dou, Tokyo, Japan (in Japanese).
– reference: 15. Yoshida Y, Kashiwabara K, Hirakawa Y, et al. Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan. BMJ Open Diabetes Res Care. 2020;8:e000902.
– reference: 20. Yamagata K, Ishida K, Sairenchi T, et al. Risk factors for chronic kidney disease in a community-based population: A 10-year follow-up study. Int Soc Nep. 2007;71:159–166.
– reference: 21. Lv J, Ren C, Hu Q. Effect of statins on the treatment of early diabetic nephropathy: A systematic review and meta-analysis of nine randomized controlled trials. Ann Palliat Med. 2021;10:11548–11557.
– reference: 26. Huebschmann AG, Huxley RR, Kohrt WM, et al. Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia. 2019;62:1761–1772.
– reference: 9. Szkio M, Nieto FJ. Epidemiology: beyond the basics. 4th ed. pp. 157, 2019, Jones & Bartlett Learning, Burlington, Massachusetts.
– reference: 18. American Diabetes Association. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes - 2024. Diabetes Care. 2024;47:S219–S230.
– reference: 22. Yamana H, Moriwaki M, Horiguchi H, et al. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27:476–482.
– reference: 11. Vandenbroucke J, Pearce N. Point: Incident exposures, prevalent exposures, and causal inference: Does limiting studies to persons who are followed from first exposure onward damage epidemiology? Am J Epidemiol. 2015;182:826–833.
– reference: 12. Hernán MA. Counterpoint: Epidemiology to guide decision-making: Moving away from practice-free research. Am J Epidemiol. 2015;182:834–839.
– reference: 13. Brookhart MA. Counterpoint: The treatment decision design. Am J Epidemiol. 2015;182:840–845.
– reference: 1. Ministry of Health,. Labour and Welfare. The National Health and Nutrition Survey in Japan, 2019 (in Japanese). Available at https://www.mhlw.go.jp/content/10900000/000687163.pdf pp.20 Last accessed March 13, 2024
– reference: 5. Retnakaran R, Cull CA, Thorne KI, et al. Risk factors for renal dysfunction in type 2 diabetes: UK Prospective Diabetes Study 74. Diabetes. 2006;55:1832–1839.
– reference: 8. Makino H. Diabetic nephropathy development and progression mechanism and treatment. pp. 6, 1999, Shindan to Chiryo Sha. (in Japanese).
– reference: 3. Yokoyama H, Okudaira M, Otani T, et al. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Kidney Int. 2000;58:302–311.
– reference: 25. He F, Xia X, Wu XF, et al. Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis. Diabetetologia. 2013;56:457–466.
– reference: 7. Sone H, Saitou Y, Yoshimura Y, et al. Diabetes mellitus and complications recent trends in the Japanese population. Jpn J Internal Medicine. 2004;93:131–138 (in Japanese).
– reference: 2. Hanafusa N, Abe M, Joki N, et al. 2021 Annual Dialysis Data Report, JSDT Renal Data Registry. J Jpn Soc Dial Ther. 2022;55:665–723 (in Japanese).
– reference: 10. Hernán MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15:615–625.
– reference: 23. Tanaka H, Tomio J, Sugiyama T, et al. Process quality of diabetes care under favorable access to healthcare: a 2-year longitudinal study using claims data in Japan. BMJ Open Diabetes Res Care. 2016;4:e000291.
– reference: 14. Vandenbroucke J, Pearce N. Response to point-counterpoint: Vandenbroucke and Pearce respond to “Incident and Prevalent Exposures and Causal Inference”. Am J Epidemiol. 2015;182;846–847.
– reference: 27. Gibson AA, Cox E, Schneuer F, et al. Sex differences in risk of incident microvascular and macrovascular complications: a population-based data-linkage study among 25713 people with diabetes. J Epidemiol Community Health. 2024;10;78:479–486.
– reference: 17. KDIGO 2022 Clinical Practice Guideline for Diabetes management in Chronic Kidney Disease. Available at https://pubmed.ncbi.nlm.nih.gov/36272764/ pp. 59 Last accessed October 27, 2024.
– reference: 24. Mitri J, Sugiyama T, Tanaka H, et al. Understanding the quality of diabetes care in Japan: a systematic review of the literature. Diabetology Int. 2022;13:41–48.
– ident: 13
  doi: 10.1093/aje/kwv214
– ident: 5
  doi: 10.2337/db05-1620
– ident: 4
– ident: 26
  doi: 10.1007/s00125-019-4939-5
– ident: 19
  doi: 10.1097/MD.0000000000003013
– ident: 22
  doi: 10.1016/j.je.2016.09.009
– ident: 10
  doi: 10.1097/01.ede.0000135174.63482.43
– ident: 21
  doi: 10.21037/apm-21-2673
– ident: 24
  doi: 10.1007/s13340-021-00497-3
– ident: 11
  doi: 10.1093/aje/kwv225
– ident: 27
  doi: 10.1136/jech-2023-221759
– ident: 12
  doi: 10.1093/aje/kwv215
– ident: 9
– ident: 7
– ident: 17
– ident: 15
  doi: 10.1136/bmjdrc-2019-000902
– ident: 2
  doi: 10.4009/jsdt.55.665
– ident: 16
  doi: 10.1053/j.ajkd.2008.12.034
– ident: 1
– ident: 23
  doi: 10.1136/bmjdrc-2016-000291
– ident: 20
  doi: 10.1038/sj.ki.5002017
– ident: 3
  doi: 10.1046/j.1523-1755.2000.00166.x
– ident: 6
  doi: 10.2337/diacare.26.3.638
– ident: 14
  doi: 10.1093/aje/kwv219
– ident: 18
  doi: 10.2337/dc24-S011
– ident: 8
– ident: 25
  doi: 10.1007/s00125-012-2796-6
SSID ssj0002771095
Score 2.2988095
Snippet BACKGROUNDDiabetic nephropathy is a common complication of diabetes. We investigated the risk factors for diabetic nephropathy in individuals newly diagnosed...
INTRODUCTION: Diabetic nephropathy is a common complication of diabetes. We investigated the risk factors for diabetic nephropathy in individuals newly...
Diabetic nephropathy is a common complication of diabetes. We investigated the risk factors for diabetic nephropathy in individuals newly diagnosed with type 2...
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
nii
jstage
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 71
SubjectTerms hypertension treatment
new type 2 diabetes
Onset of diabetic nephropathy
Original
risk factor
Title Risk factors for nephropathy in individuals with new-onset type 2 diabetes undergoing treatment for hypertension: A retrospective analysis using the Diagnosis Procedure Combination database
URI https://www.jstage.jst.go.jp/article/ace/7/3/7_25009/_article/-char/en
https://cir.nii.ac.jp/crid/1390866117160927104
https://www.ncbi.nlm.nih.gov/pubmed/40697797
https://www.proquest.com/docview/3232488661
https://pubmed.ncbi.nlm.nih.gov/PMC12279404
https://doi.org/10.37737/ace.25009
UnpaywallVersion publishedVersion
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Annals of Clinical Epidemiology, 2025/07/01, Vol.7(3), pp.71-79
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2434-4338
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0002771095
  issn: 2434-4338
  databaseCode: M~E
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2434-4338
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0002771095
  issn: 2434-4338
  databaseCode: RPM
  dateStart: 20210101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdGh4AXvtkCbDKw15TGduKEt2owTUibEKLSeIpi16Zhk1uliabxv_G_ced8aB1o4qF9iC9Nozv7fmff746QA8ZkYu08DW2hTAj4X-GcS0PBrIqtwrxvDBRPTpPjmfh8Fp9tkbc9F-ba-T2Xksv3hTZjcNPI0dtOYsDbI7I9O_0y_Y5d4wQXSPlJ27qjN27Y8DR3fwLYQhb9HVeW_0KTfydF3m_cqri6LC4urnmco0fksP-vbaLJ-bip1Vj_ulHG8faXeUwedoCTTlsLeUK2jHtK7p10R-rPyO-v5fqcdm13KEBY6swKeycANLyipaPlQNlaU9y1hfHLEHOwa4r7t5TRfv-WIiGt-rEEb0iHBHb_kwsQrHyu_NJ9oFNambpa9iRPWnSFUSgm4cOtC0M_thmAcM0zGeZNZSgsXRDGe0uimNiKDvg5mR19-nZ4HHY9HULNOctCGxeaxanSqbCCK81VlsCIgihQSqRzMynn0kapKrQ0UaYjZbVmWiYCQq8s5i_IyC2d2SVUGjtnspgAgkpFDLKmgNVpomKhlUm0Cci7Xv_5qi3dkUPI4zWRgyZyr4mAJK1pDDLdlPUiMufw8YLDdaTDwZoSkD0wpRx0Bd-AoyE2TCIsPjTJGMA2EZA3vZHlMGXxHKZwZtmsc44oNkXxgOy0Rjc8HInIUmYyIOmGOQ4CWA58c8SVC18WPMJikAIffDBY7i0v_vL_xF6RBwxbHvsM5ddkVFeN2QMcVqt9vzW2303HP31BNmY
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdGhxgvfDMCDBnYa0pjO3HCWzWYJqRNCFFpPEW266xhk1Oljabxv_G_ced8aB1o4qF9iC9Nozv7fmff746QfcZkUhTzNCyUtiHgf41zLg0FK3RcaMz7xkDx-CQ5mokvp_HpFnnXc2Gund9zKbn8oIwdg5tGjt52EgPeHpHt2cnX6Q_sGie4QMpP2tYdvXHDhqe5-xPAFrLo77iy_Bea_DspcqdxS3V1qS4urnmcw4fkoP-vbaLJ-bhZ67H5daOM4-0v84g86AAnnbYW8phsWfeE3DvujtSfkt_fytU57druUICw1Nkl9k4AaHhFS0fLgbK1orhrC-OXIeZgrynu31JG-_1bioS0-qwCb0iHBHb_kwsQrH2ufOU-0imt7bquepInVV1hFIpJ-HDrwtJPbQYgXPNMhnlTWwpLF4Tx3pIoJraiA35GZoefvx8chV1Ph9BwzrKwiJVhcapNKgrBteE6S2BEQxQoJdK5mZRzWUSpVkbaKDORLoxhRiYCQq8s5s_JyFXOviBU2mLOpJoAgkpFDLJWweo00bEw2ibGBuR9r_982ZbuyCHk8ZrIQRO510RAktY0BpluynoRmXP4eMHhOtLhYE0JyB6YUg66gm_A0RAbJhEWH5pkDGCbCMjb3shymLJ4DqOcrZpVzhHFpigekN3W6IaHIxFZykwGJN0wx0EAy4Fvjrhy4cuCR1gMUuCD9wfLveXFX_6f2Ctyn2HLY5-h_JqM1nVj9wCHrfWbbiL-ATwrNVY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Risk+factors+for+nephropathy+in+individuals+with+new-onset+type+2+diabetes+undergoing+treatment+for+hypertension%3A+A+retrospective+analysis+using+the+Diagnosis+Procedure+Combination+database&rft.jtitle=Annals+of+clinical+epidemiology&rft.au=Ishigaki+Suzuki%2C+Tomoko&rft.au=Saito+Oba%2C+Mari&rft.au=Uemura%2C+Kohei&rft.date=2025-07-01&rft.issn=2434-4338&rft.eissn=2434-4338&rft.volume=7&rft.issue=3&rft.spage=71&rft.epage=79&rft_id=info:doi/10.37737%2Face.25009&rft.externalDBID=n%2Fa&rft.externalDocID=10_37737_ace_25009
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2434-4338&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2434-4338&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2434-4338&client=summon